30May/13

Editorial: A missing link? Monocyte activation by uremic toxins in cardiorenal … – Journal of Leukocyte Biology (subscription)

Editorial: A missing link? Monocyte activation by uremic toxins in cardiorenal
Journal of Leukocyte Biology (subscription)
Editorial: A missing link? Monocyte activation by uremic toxins in cardiorenal syndrome. Ehrin J. Armstrong*,; Jennifer L. Granick† and; Scott I. Simon*,1. *Division of Cardiovascular Medicine, UC Davis Medical Center, University of California, Davis

and more »

30May/13

Chhattisgarh attack Live: Air Force to up surveillance in Naxal areas – Firstpost


Economic Times

Chhattisgarh attack Live: Air Force to up surveillance in Naxal areas
Firstpost
10.50 am: Indian Air Force upping surveillance in Naxal areas. The Indian Air Force is upgrading its surveillance capacity in Maoist-hit areas after the recent failure of unmanned aerial vehicles (UAVs) operating in Chhattisgarh, reported DNA
Indian state on high alert following deadly Maoist attackLos Angeles Times
Rahul Gandhi visits injured Congress leaders, activists in Raipur hospitalDaily News & Analysis
Chhattisgarh Naxal attack: Top state Congress leaders among 25 killedNDTV

all 875 news articles »

30May/13

Prolonged use of painkillers could raise heart attack risk – Zee News


Zee News

Prolonged use of painkillers could raise heart attack risk
Zee News
In the study, the researchers analysed 639 random drug trials and assembled information on more than 350,000 patients, and found that for every 1,000 arthritis sufferers, the rate of people who suffered a “major vascular event” like heart attack
Painkiller taken for arthritis put your heart at riskDaily News & Analysis

all 84 news articles »

29May/13

Pfizer Halts Phase III Trial of Cancer Drug in NHL Due to Futility – Pharmaceutical Technology Magazine

Pfizer Halts Phase III Trial of Cancer Drug in NHL Due to Futility
Pharmaceutical Technology Magazine
The drug was administered once a month in combination with Roche’s Rituxan (rituximab) and compared with either Teva’s Treanda (bendamustine) plus rituximab , or Eli Lilly’s Gemzar (gemcitabine) plus rituximab. An independent data monitoring committee